Approval · Notice of Compliance 13963 · 2012
TECTA: Notice of Compliance 13963
Issued December 21, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13963
- Date
- December 21, 2012
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- H+,k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECTA | 02267233 | Marketed |
Medicinal ingredients
- PANTOPRAZOLE MAGNESIUM 40 MG per TAB